{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T12:40:46Z","timestamp":1740141646509,"version":"3.37.3"},"reference-count":34,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2010,5,31]],"date-time":"2010-05-31T00:00:00Z","timestamp":1275264000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J Dermatology"],"published-print":{"date-parts":[[2010,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold>One of the major goals of pemphigus therapy is to reduce the patient\u2019s cumulative exposure to systemic corticosteroids. To investigate the efficacy of enteric\u2010coated mycophenolate sodium (EC\u2010MPS), 10 patients with active, refractory pemphigus vulgaris (PV) or foliaceous (PF) were treated with EC\u2010MPS (1440\u2003mg daily) and prednisone (75\u2003mg daily) over 18\u2003months.<\/jats:p><jats:p><jats:bold>Observations\u2002<\/jats:bold>Following EC\u2010MPS\/prednisone therapy, disease progression was inhibited between days 30 and 45 in 9\/10 patients (8 PV; 1 PF). At 18\u2003months, 8\/9 PV patients had clinically quiescent disease; EC\u2010MPS therapy was no longer required in two patients as a result of disease remission. The remaining PV patient showed no response to treatment. The PF patient also had clinically quiescent disease but with high levels of anti\u2010desmoglein\u20101. ECMPS dose was reduced to 720\u2003mg daily in 4\/9 patients by month 6. Average daily prednisone requirement decreased to 25\u2003mg at 6\u2003months and to 15\u2003mg at 18\u2003months. Three adverse events were reported: headache (two cases; one mild and one moderate) and significant increase in blood glucose (one case; moderate).<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold>Enteric\u2010coated mycophenolate sodium is effective and safe as an adjuvant therapy in patients with refractory pemphigus and may be effective even in patients whose disease is unresponsive to azathioprine.<\/jats:p>","DOI":"10.1111\/j.1365-4632.2009.04291.x","type":"journal-article","created":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T03:58:34Z","timestamp":1275364714000},"page":"693-699","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Enteric\u2010coated mycophenolate sodium in the treatment of refractory pemphigus"],"prefix":"10.1111","volume":"49","author":[{"given":"Maria Rita","family":"Bongiorno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Pistone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Spyridoula","family":"Doukaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Aric\u00f2","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,5,31]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-92-3-396"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1980.01640330073017"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1439-0353.2004.04702.x-i1"},{"key":"e_1_2_6_5_2","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1681\/ASN.V11122366","article-title":"Effect of mycophenolate mofetil on long\u2010term outcomes in African\u2010American renal transplant recipients","volume":"11","author":"Meier\u2010Kriesche HU","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200006150-00033"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)63084-X"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1600-6143.2003.00337.x"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199904150-00811"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2005.01.063"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1600-6143.2003.00321.x"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2004.12.048"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2006.04.005"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2000.03660.x"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1976.01630310024005"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(00)90213-5"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.1994.tb01811.x"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(82)70111-2"},{"key":"e_1_2_6_19_2","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1001\/archderm.1984.01650430127024","article-title":"Adjuvant therapy for pemphigus","volume":"120","author":"Bystryn J","year":"1984","journal-title":"Arch Dermatol"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1996.03890260105016"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199508000-00003"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199604150-00008"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)10310-X"},{"key":"e_1_2_6_24_2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1399-0012.1996.tb00651.x","article-title":"Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF)","volume":"10","author":"Allison AC","year":"1996","journal-title":"Clin Transplant"},{"key":"e_1_2_6_25_2","first-page":"S14","article-title":"Mycophenolate mofetil","volume":"48","author":"Sollinger HW","year":"1995","journal-title":"Kidney Int"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/14.1.58"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/223848a0"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1D063"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1080\/09546630600964999"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000209411.66790.b3"},{"issue":"2","key":"e_1_2_6_31_2","first-page":"487","article-title":"A three\u2010month prospective, open\u2010label, two cohort study to investigate the efficacy, safety and tolerability of EC\u2010MPS in combination with cyclosporine or tacrolimus in renal transplant recipients with GI intolerance","volume":"6","author":"Tomlanovich S","year":"2006","journal-title":"Am J Transpl"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)80092-X"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(98)70334-2"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(00)90231-7"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.135.1.54"}],"container-title":["International Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-4632.2009.04291.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-4632.2009.04291.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:37:14Z","timestamp":1740137834000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-4632.2009.04291.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,31]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["10.1111\/j.1365-4632.2009.04291.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-4632.2009.04291.x","archive":["Portico"],"relation":{},"ISSN":["0011-9059","1365-4632"],"issn-type":[{"type":"print","value":"0011-9059"},{"type":"electronic","value":"1365-4632"}],"subject":[],"published":{"date-parts":[[2010,5,31]]},"assertion":[{"value":"2010-05-31","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}